Ep Wealth Advisors, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Ep Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$55.89 - $101.89 $86,070 - $156,910	-1,540 Reduced 10.0%	13,862 $1.36 Million
Q4 2021 Feb 17, 2022	BUY	$72.34 - $95.09 $731,068 - $960,979	10,106 Added 190.82%	15,402 $1.31 Million
Q3 2021 Nov 23, 2021	SELL	$78.35 - $105.02 $3.51 Million - $4.71 Million	-44,820 Reduced 89.43%	5,296 $423,000
Q3 2021 Nov 16, 2021	BUY	$78.35 - $105.02 $3.51 Million - $4.71 Million	44,820 Added 846.3%	50,116 $423,000
Q4 2020 Feb 18, 2021	BUY	$110.06 - $133.7 $582,877 - $708,075	5,296 New	5,296 $589,000

298

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.9B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ep Wealth Advisors, LLC with notifications on news.